Skip to main content
. 2022 Nov 1;22:457. doi: 10.1186/s12872-022-02881-6

Table 1.

Baseline characteristics in the clinical recurrence and non-recurrence groups

Parameters No recurrence
N = 90
Clinical recurrence
N = 29
P-value
Age (years) 68.0 ± 8.9 69.0 ± 7.0 0.523
Gender (male/female, %) 57/33 (63.3) 18/11 (62.1) 0.902
Body mass index (kg/m2) 23.5 ± 5.1 22.9 ± 5.5 0.569
Current or former smoker (%) 49 (54.4) 14 (48.3) 0.563
Persistent AF (%) 42 (46.7) 20 (69.0) 0.037
Comorbidity
Type 2 diabetes mellitus (%) 14 (15.6) 6 (20.7) 0.571
Hypertension (%) 48 (53.3) 18 (62.1) 0.410
Dyslipidemia (%) 33 (36.7) 6 (20.7) 0.111
Chronic kidney disease (%) 33 (36.7) 10 (34.5) 0.831
Coronary artery disease (%) 7 (7.8) 3 (10.3) 0.704
Congestive heart failure (%) 25 (27.8) 7 (25.0) 0.773
Previous stroke (%) 13 (14.4) 6 (20.7) 0.400
CHADS2 score 1.5 ± 1.2 1.7 ± 1.0 0.564
CHA2DS2-VASc score 2.6 ± 1.6 3.0 ± 1.3 0.258
Medication at admission (%)
ACE inhibitor or ARB (%) 44 (48.9) 14 (48.3) 0.954
Beta-blocker (%) 48 (53.3) 14 (48.3) 0.635
Echocardiography
LA dimension (mm) 40.0 ± 5.8 42.7 ± 7.5 0.049
LV ejection fraction (%) 64.0 ± 13.6 67.4 ± 11.9 0.228
E/e’ 12.6 ± 5.0 11.9 ± 3.2 0.375
LAA emptying velocity (m/s) 48.6 ± 20.9 39.0 ± 20.0 0.049
Primary measurements
Anterior LA-LVA (cm2) 9.1 ± 5.9 18.7 ± 13.0 0.001
Posterior LA-LVA (cm2) 5.0 ± 4.5 9.7 ± 7.0 0.002
Anterior model LA-CV (m/s) 0.89 ± 0.24 0.74 ± 0.23 0.005
Posterior model LA-CV (m/s) 0.95 ± 0.24 0.92 ± 0.29 0.575
Coefficient of variation in anterior LA-CV (m/s) 0.46 ± 0.44 0.39 ± 0.42 0.458
Coefficient of variation in posterior LA-CV (m/s) 0.57 ± 0.63 0.46 ± 0.42 0.400

Values are expressed as mean ± standard deviation or number (percentage). AF, atrial fibrillation; ACE, angiotensin converting enzyme; ARB, angiotensin II receptor blocker; LA, left atrium; LV, left ventricular; LAA, left atrial appendage; LVA, low voltage area; CV, conduction velocity